Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Intercytex (ICX-RHY/Vavelta Asset)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A skin repair and rejuvenation product. The asset has been designed to improve the structure, function and appearance of skin damaged by medical conditions such as EB, scarring and associated scar contractures or the aging process.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Business Products and Services
Other Industries
Pharmaceuticals
Primary Office
  • Oaks Business Park, Innovation House
  • Crewe Road
  • Manchester M23 9QR
  • England, United Kingdom

Intercytex (ICX-RHY/Vavelta Asset) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Intercytex (ICX-RHY/Vavelta Asset)‘s full profile, request access.

Request full access to PitchBook

Intercytex (ICX-RHY/Vavelta Asset) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Intercytex (ICX-RHY/Vavelta Asset)‘s full profile, request access.

Request full access to PitchBook